3.26 0.24 (7.95%)
166.6K XNAS Volume
XNAS 21 Mar, 2025 4:01 PM (EDT)
Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|
Barbra C. Keck | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 100,000 | 100,000 | - | - | Employee stock option (Right to Buy) | |
Sriram Peruvemba | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 20,000 | 20,000 | - | - | Employee stock option (Right to Buy) | |
Klaas de Boer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 20,000 | 20,000 | - | - | Employee stock option (Right to Buy) | |
Ian Tudor Jenks | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 165,000 | 165,000 | - | - | Employee stock option (Right to Buy) | |
Ian Tudor Jenks | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 16,000 | 16,000 | - | - | Employee stock option (Right to Buy) | |
Steven P. DenBaars | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 20,000 | 20,000 | - | - | Employee stock option (Right to Buy) | |
Melisa A. Denis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 20,000 | 20,000 | - | - | Employee stock option (Right to Buy) | |
Beverley Brown | Chief Scientist | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 49,000 | 49,000 | - | - | Employee stock option (Right to Buy) | |
Simon Ogier | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 49,000 | 49,000 | - | - | Employee stock option (Right to Buy) | |
Klaas de Boer | Director | 30 May 2024 | 5,715 | 11,430 | - | - | Common Stock | ||
Klaas de Boer | Director | 30 May 2024 | 50 | 0 | - | - | Series A-2 Convertible Preferred Stock |